Avon Lake, OH, United States of America

David William Weaver


Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2002-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Spotlight: David William Weaver from Avon Lake, OH

Introduction

David William Weaver is an accomplished inventor based in Avon Lake, Ohio. With a total of three patents to his name, Weaver has made significant contributions to the field of controlled release pharmaceuticals, demonstrating a unique approach to the preparation of polyacrylic acid granules.

Latest Patents

Weaver's most recent patents focus on "Controlled Release Polyacrylic Acid Granules and a Process for Preparing the Same." This innovation describes a method for creating flowable polyacrylic acid granules that possess an increased bulk density compared to their polymerized counterparts, while also minimizing dust production. The granules produced through this process are specifically designed to be utilized in controlled release tablets, particularly in the pharmaceutical realm. Remarkably, the controlled release properties of these tablets surpass those formed from granules prepared using traditional granulation methods.

Career Highlights

Throughout his career, David William Weaver has been associated with notable companies, including Noveon IP Holdings Corporation and Pmd Holdings Corporation. His work at these organizations has underpinned his reputation as a skilled inventor with a strong focus on innovation in drug delivery systems.

Collaborations

Weaver has collaborated with distinguished colleagues like Daniel James Adams and William Robert Wilber, further enriching his experience and expertise in developing cutting-edge technologies in the pharmaceutical industry. Their teamwork has played a pivotal role in advancing the capabilities and applications of controlled release formulations.

Conclusion

David William Weaver is a noteworthy inventor whose contributions in the area of controlled release polyacrylic acid granules reflect a commitment to enhancing pharmaceutical technologies. With a solid track record and significant collaborations, Weaver continues to shape the future of drug delivery systems through his innovative approaches and groundbreaking patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…